Literature DB >> 12111545

Mammalian melatonin receptors: molecular biology and signal transduction.

Charlotte von Gall1, Jörg H Stehle, David R Weaver.   

Abstract

The pineal hormone, melatonin, is an important regulator of seasonal reproduction and circadian rhythms. Its effects are mediated via high-affinity melatonin receptors, located on cells of the pituitary pars tuberalis (PT) and suprachiasmatic nucleus (SCN), respectively. Two subtypes of mammalian melatonin receptors have been cloned and characterized, the MT1 (Mel(1a)) and the MT2 (Mel(1b)) melatonin receptor subtypes. Both subtypes are members of the seven-transmembrane G protein-coupled receptor family. By using recombinant melatonin receptors it has been shown that the MT1 melatonin receptor is coupled to different G proteins that mediate adenylyl cyclase inhibition and phospholipase C beta activation. The MT2 receptor is also coupled to inhibition of adenylyl cyclase and additionally it inhibits the soluble guanylyl cyclase pathway. In mice with a targeted deletion of the MT1 receptor, the acute inhibitory effects of melatonin on SCN multiunit activity are completely abolished, while the phase-shifting responses to melatonin (given in physiological concentrations) appear normal. Furthermore, melatonin inhibits the phosphorylation of the transcription factor cyclic AMP response element binding protein, induced by the pituitary adenylate cyclase-activating polypeptide in SCN cells predominantly via the MT1 receptor. However, a functional MT2 receptor in the rodent SCN is partially able to compensate for the absence of the MT1 receptor in MT1 receptor-deficient mice. These findings indicate redundant and non-redundant roles of the receptor subtypes in regulating SCN function. In the PT, a functional MT1 receptor is essential for the rhythmic synthesis of the clock gene product mPER1. Melatonin produces a long-lasting sensitization of adenylyl cyclase and thus amplifies cyclic AMP signaling when melatonin levels decline at dawn. This action of melatonin amplifies gene expression rhythms in the PT and provides a mechanism for reinforcing rhythmicity in peripheral tissues which themselves lack the capacity for self-sustained oscillation. Mice with targeted deletion of melatonin receptor subtypes provide an excellent model to understand cellular mechanisms through which melatonin modulates circadian and photoperiodic rhythmicity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12111545     DOI: 10.1007/s00441-002-0581-4

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  101 in total

Review 1.  The retinal pigment epithelium in health and disease.

Authors:  J R Sparrow; D Hicks; C P Hamel
Journal:  Curr Mol Med       Date:  2010-12       Impact factor: 2.222

2.  Ozone exposure of Flinders Sensitive Line rats is a rodent translational model of neurobiological oxidative stress with relevance for depression and antidepressant response.

Authors:  Mmalebuso L Mokoena; Brian H Harvey; Francois Viljoen; Susanna M Ellis; Christiaan B Brink
Journal:  Psychopharmacology (Berl)       Date:  2015-04-17       Impact factor: 4.530

Review 3.  Hepatoprotective actions of melatonin: possible mediation by melatonin receptors.

Authors:  Alexander M Mathes
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

4.  Effects of melatonin and age on gene expression in mouse CNS using microarray analysis.

Authors:  Edward H Sharman; Stephen C Bondy; Kaizhi G Sharman; Debomoy Lahiri; Carl W Cotman; Victoria M Perreau
Journal:  Neurochem Int       Date:  2006-11-21       Impact factor: 3.921

5.  Daily variations in plasma melatonin and melatonin receptor (MT1), PER1 and CRY1 expression in suprachiasmatic nuclei of tropical squirrel, Funambulus pennanti.

Authors:  Sameer Gupta; Chandana Haldar; Sarika Singh
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2013-07-13       Impact factor: 1.836

Review 6.  Expression and putative functions of melatonin receptors in malignant cells and tissues.

Authors:  Cem Ekmekcioglu
Journal:  Wien Med Wochenschr       Date:  2014-07-15

7.  Randomized controlled trial of pharmacological replacement of melatonin for sleep disruption in individuals with tetraplegia.

Authors:  Jamie M Zeitzer; Ban Ku; Doug Ota; B Jenny Kiratli
Journal:  J Spinal Cord Med       Date:  2013-10-24       Impact factor: 1.985

8.  Efficacy and safety of 6-month nightly ramelteon administration in adults with chronic primary insomnia.

Authors:  Geert Mayer; Sherry Wang-Weigand; Barbara Roth-Schechter; Reiner Lehmann; Corinne Staner; Markku Partinen
Journal:  Sleep       Date:  2009-03       Impact factor: 5.849

9.  MT1 melatonin receptors mediate somatic, behavioral, and reproductive neuroendocrine responses to photoperiod and melatonin in Siberian hamsters (Phodopus sungorus).

Authors:  Brian J Prendergast
Journal:  Endocrinology       Date:  2009-12-04       Impact factor: 4.736

10.  Exacerbated mechanical allodynia in rats with depression-like behavior.

Authors:  Qing Zeng; Shuxing Wang; Grewo Lim; Liling Yang; Ji Mao; Backil Sung; Yang Chang; Jeong-Ae Lim; Gongshe Guo; Jianren Mao
Journal:  Brain Res       Date:  2008-01-26       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.